COVID-19

 

HOVON:

We would like to inform you that the HOVON Data Center (HDC) and the HOVON Safety Desk will remain fully operational to ensure the safety of the patients included in HOVON trials.

The distribution and delivery of the study medicinal products are being closely monitored and we will inform you accordingly if any actions need to be taken.

The central laboratories are also still fully functioning.

At the moment it is possible to include patients in all active HOVON trials.

 

Participating sites:

Please make sure to inform the HOVON Data Center per e-mail (hdc@erasmusmc.nl) if your hospital has decided to temporarily halt patient inclusion in clinical trials following the COVID-19 outbreak.

In case patient visits or study procedures cannot be performed per protocol due to the COVID-19, please document this in the patient files.

 

Contact:

Given the situation surrounding the Corona virus, the HOVON central Office (HCB) and the HOVON Data Center (HDC) are temporarily unavailable by phone.

Please send all (urgent) question via email, these will be picked up and processed by the team as soon as possible. We hope for your understanding of this situation.

For study specific questions, you can contact the concerning HOVON Trial Manager or our general e-mail address (hdc@erasmusmc.nl - Please include HOVON study number as reference). Thank you for your cooperation.

 

HOVON Central Office (HCB): hovonbureau@vumc.nl

HOVON Data Center (HDC): hdc@erasmusmc.nl

 

With kind regards, Marleen Breems (HOVON General Director) and Bianca Backx (manager HDC)


SLUITEN
sluit venster

Log in

Username Password Forgotten your user name and/or password? Want to request a user name and/or password?

Search in the HOVON website

Studies (all)


Study name Status Echelon level Stage Age Updated Included patients Active sites
HOVON-associated Transplant BRaVE Closed n/a - >=18 03-05-2018 n/a n/a
HOVON-associated TARGET study Open Level A - >= 18 01-04-2019 n/a n/a
HOVON-associated SADAL trial (Protocol KCP-330-009) Closed Level A 2nd line >=18 14-01-2019 n/a n/a
HOVON Pomalidomide project Open n/a 3rd line >18 17-11-2015 n/a n/a
HOVON-associated PLMA25 NK-cell study Closed n/a - >= 55 29-09-2015 n/a n/a
HOVON-associated Murano study Closed n/a 2nd line >= 18 31-08-2015 n/a n/a
HOVON-associated Innate allo-SCT Closed n/a - >18 19-11-2018 n/a n/a
HOVON-associated GO27878 study (Cavalli study) Closed n/a - >=18 09-02-2017 n/a n/a
HOVON-associated GLOW study Closed Limited site selection 3rd line >= 18 10-01-2020 n/a n/a
HOVON-associated EMN17 Perseus Trial Closed Level A - 18-70 09-12-2019 n/a n/a
HOVON-associated CC-122 NHL-001 Closed n/a 2nd line >=18 03-12-2018 n/a n/a
HOVON-associated CARINA (Protocol 54767414LYM2001) Closed Limited site selection 3rd line >=18 07-12-2016 n/a n/a
HOVON-associated Anti-CD20 cGVHD study Closed n/a - >=18 09-12-2015 n/a n/a
HOVON-associated Acerta CL-007 Closed n/a - >65 OR >18 - 65 23-03-2018 n/a n/a
HOVON-associated Acerta CL-006 Closed n/a 2nd line >=18 23-03-2018 n/a n/a
HOVON-associated CMV pp65 specific T-cells Open n/a - 0 - 75 18-10-2012 n/a n/a
HOVON-associated ACE WM-001 Closed n/a - >=18 24-12-2015 n/a n/a
HOVON-associated ACE LY-004 Closed n/a - >=18 24-12-2015 n/a n/a
HOVON 902 DLBCL Open Level A, Level B, Level C-HIC, Level C-SCT, Level C-HIC & C-SCT, Level D - ≥ 18 19-03-2020 n/a n/a
HOVON 900 DLBCL screening Closed 1st line > 18 year 19-06-2019 1198 23
HOVON 159 CLL Planned Level A, Level B, Level C-HIC, Level C-SCT, Level C-HIC & C-SCT, Level D Initieel ≥ 18 22-08-2019 n/a n/a
HOVON 158 CLL Planned Level D Initieel ≥18 06-06-2019 n/a n/a
HOVON 157 AML Closed Limited site selection 1st line >= 18 18-09-2019 n/a n/a
HOVON 156 AML Open Level C-HIC & C-SCT - >=18 y 06-03-2020 n/a 12
HOVON 155 AML Open Limited site selection 1st line >=18 04-03-2020 n/a 6
HOVON 153 NIVEAU Planned Level D 2nd line >18 30-12-2019 n/a n/a
HOVON 152 DLBCL Open Level D 1st line ≥ 18 27-03-2020 n/a n/a
HOVON 151 DLBCL Open Level A, Level B, Level C-HIC, Level C-SCT 1st line 18 - 75 25-03-2020 8 31
HOVON 150 AML Open Level C-HIC & C-SCT 1st line >=18 jaar 11-03-2020 n/a 32
HOVON 149 AL Amyloidosis Closed n/a - 18 - 70 03-05-2018 n/a n/a
HOVON 148 AML Closed Level A - 18 - 70 12-03-2020 12 5
HOVON 147 SMM Open Level C-HIC 2nd line >=18 years 08-10-2019 14 6
HOVON 146 ALL Open Level A, Level B 1st line 18 - 70 04-03-2020 n/a n/a
HOVON 145 AML Open Level A 2nd line 18-70 13-08-2019 n/a 5
HOVON 144 PREBEN Open Level D 2nd line 18-70 en 71-85 09-12-2019 n/a 8
HOVON 143 MM Closed Level D 1st line > 18 26-09-2019 130 49
HOVON 142 CML -SUSTRENIM-CML1415 Open Level A, Level B, Level C-HIC & C-SCT 1st line ≥18 11-02-2020 n/a 6
HOVON 141 CLL Closed Level D 2nd line >=18 22-10-2019 225 46
HOVON 140 CLL Closed Level D 1st line >=18 14-11-2019 n/a 38
HOVON 139 CLL (GIVE) Closed Level D 1st line >=18 29-10-2019 70 25
HOVON 138 APL Open Limited site selection 1st line 18 - 65 years 24-01-2020 n/a 12
HOVON 136 NHL Open Level B 2nd line >18 years 16-03-2020 9 9
HOVON 135 AML / SAKK Closed Limited site selection 1st line >=66 18-06-2018 147 34
HOVON 134 MF Open Level A - 18 - 70 y 21-01-2020 28 6
HOVON 133 MCL (TRIANGLE) Open Level D - 18 - 65 28-06-2019 n/a 32
HOVON 132 AML / SAKK Closed Limited site selection 1st line 18 - 65 30-10-2019 909 52
HOVON 131 MM / IFM 2015-01 Closed n/a 1st line 18-65 24-09-2019 n/a n/a
HOVON 130 NHL Closed Level D 1st line ≥ 18 20-09-2018 83 23
HOVON 129 PCL Open Level A 2nd line >18 yrs 18-02-2020 n/a 23
HOVON 127 BL Open Level C-HIC 1st line 18-75 17-09-2019 58 22
HOVON 126 MM Closed Limited site selection 1st line 03-05-2018 143 40
HOVON 124 WM Closed Limited site selection 2nd line >=18 y 08-10-2019 60 21
HOVON 123 MM Closed Level D 1st line >= 75 15-05-2019 240 46
HOVON 121 CLLM1/GCLLSG Closed Level D - ≥ 18 03-05-2018 n/a 4
HOVON 120 NHL (ZEST) Closed n/a 2nd line > = 60 03-05-2018 n/a n/a
HOVON 119 MCL Closed Level D 1st line >= 60 07-02-2020 n/a 22
HOVON 117 ALL On hold n/a 1st line >=55 03-05-2018 n/a 1
HOVON 116 AML Closed Level A 1st line 18 - 70 03-05-2018 140 7
HOVON 115 Double UCBT Closed Level A - 03-05-2018 70 6
HOVON 114 MM Open Limited site selection 2nd line >= 18 24-02-2020 n/a 33
HOVON 113 MSC Closed Level A, Level B 2nd line Any age 04-11-2019 42 8
HOVON 112 MSC On hold Level A 1st line Any age 03-05-2018 39 2
HOVON 110 FL Closed n/a 2nd line >= 18 years 16-01-2020 109 51
HOVON 109 CLL Closed Limited site selection 1st line 65 years – 80 years, inclusive; 18 - 64 years, inclusive, with CIRS ≥7 24-09-2019 63 34
HOVON 108 MM Closed Level A 2nd line 18-65 19-10-2018 30 7
HOVON 107 MOBILIZATION Closed Level A - 18-60 07-12-2018 38 4
HOVON 106 DOUBLE UCBT Closed n/a - 18-65 03-05-2018 41 5
HOVON 105 PCNSL / ALLG NHL24 Closed Level C-HIC 1st line 18 - 70 07-11-2019 200 28
HOVON 104 AL AMYLOIDOSIS Closed n/a 1st line 18-70 07-12-2018 57 18
HOVON 103 AML Closed Level C-HIC 1st line >=66 30-12-2019 678 30
HOVON 102 AML Closed Limited site selection 1st line 18 - 65 07-12-2018 862 45
HOVON 101 CLL/OMB112517 Closed n/a 2nd line >= 18 03-05-2018 n/a 19
HOVON 100 ALL / EORTC Closed Level C-SCT 3rd line 18 - 70 20-03-2019 370 30
HOVON-associated MM and haplo Closed n/a 3rd line < 66 yrs 12-03-2020 n/a n/a
HOVON 98 / OMB110928 Closed n/a 2nd line >=18 03-05-2018 n/a n/a
HOVON 97 AML Closed Level C-HIC 1st line >= 60 03-05-2018 116 25
HOVON 96 GVHD Closed n/a 1st line 18 - 70 13-11-2019 494 7
HOVON 95 MM Closed Level D 1st line 18-65 24-02-2020 n/a 189
HOVON 93 AML / EBMT Closed Level B 1st line >= 60 <= 75 03-05-2018 n/a 6
HOVON 92 AML / SAKK Closed Limited site selection 1st line 18 - 65 19-10-2018 n/a n/a
HOVON 91 T-NHL (ACT-2) Closed n/a 1st line 61-80 03-05-2018 n/a n/a
HOVON 90 T-NHL (ACT-1) Closed n/a 1st line 18 - 60 years 03-05-2018 n/a n/a
HOVON 89 MDS Closed Level D 1st line >=18 15-05-2019 184 34
HOVON 88 CLL Closed n/a 2nd line 18 - 70 03-05-2018 46 3
HOVON 87 MM Closed Level D 1st line prev. untreated > 65 or <=65 when inelig. for HDT & PCST 05-08-2019 643 90
HOVON 86 MM Closed Level C-HIC & C-SCT 2nd line >=18 03-05-2018 81 25
HOVON 85 NHL Closed n/a 2nd line >=18 03-05-2018 61 27
HOVON 84 NHL Closed n/a 1st line 18 - 80 23-12-2019 585 67
HOVON 82 Sanquin Closed n/a 1st line >= 18 03-05-2018 295 8
HOVON 81 AML Closed n/a 1st line > 60 03-05-2018 n/a n/a
HOVON 80 NHL Closed n/a 2nd line 18 - 65 03-05-2018 36 12
HOVON 79 APL / PETHEMA LPA 2005 Closed Level B 1st line 18 - 75 03-05-2018 90 11
HOVON 78 CML Closed n/a 1st line 18 - 65 20-06-2018 110 30
HOVON 77 NHL Closed n/a 1st line > 60 03-05-2018 19 24
HOVON 76 MM Closed n/a 1st line 18 - 66 19-10-2018 35 8
HOVON 75 MCL Closed n/a 1st line 18 - 65 03-05-2018 132 16
HOVON 74 ALL Closed n/a 2nd line 18 - 70 03-05-2018 2 8
HOVON 73 NHL / PRIMA Closed n/a 1st line >= 18 24-06-2019 18 14
HOVON 72 AML Closed n/a 2nd line 18 - 60 03-05-2018 2 1
HOVON 71 ALL Closed n/a 1st line 40 - 70 03-05-2018 60 21
HOVON 70 ALL Closed n/a 1st line 18 - 39 03-05-2018 54 20
HOVON 69 T-NHL Closed n/a 1st line 18 - 65 03-05-2018 20 19
HOVON 68 CLL Closed n/a 1st line 18 - 75 03-05-2018 274 71
HOVON 67 AML / SAKK Closed n/a 1st line >= 60 03-05-2018 6 9
HOVON 66 AML Closed n/a 1st line 18 - 60 03-05-2018 n/a n/a
HOVON 65 MM / GMMG HD4 Closed n/a 1st line 18 - 65 03-12-2019 828 75
HOVON 64 ITP Closed n/a 1st line > 18 03-05-2018 151 35
HOVON 63 NHL Closed n/a 1st line 18 - 65 03-05-2018 40 31
HOVON 61 NHL Closed n/a 1st line >= 65 03-05-2018 n/a 7
HOVON 60 MDS / SAKK 33/99 Closed n/a 1st line > 18 19-08-2018 6 3
HOVON 59 AML / SAKK / OSHO Closed n/a 1st line 16 - 75 03-05-2018 22 5
HOVON 58 ET Closed n/a 1st line 18 - 80 03-05-2018 7 9
HOVON 57 MM Closed n/a 1st line >= 18 03-05-2018 24 10
HOVON 55 MCL Closed n/a 1st line >=65 or 60-65 (see inclusion criteria) 03-05-2018 95 30
HOVON 54 MM Closed n/a 1st line 18 - 65 20-06-2018 87 6
HOVON 53 AML / OSHO Closed n/a 1st line 50 - 75 03-05-2018 59 10
HOVON 52 AML Closed n/a 1st line 18 - 75 03-05-2018 n/a n/a
HOVON 51 CML Closed n/a 1st line 18 - 65 19-08-2018 164 16
HOVON 50 MM Closed n/a 1st line 18 - 65 03-05-2018 555 n/a
HOVON 49 MM Closed n/a 1st line > 65 03-05-2018 344 n/a
HOVON 48 NHL / NHLFIT Closed n/a 2nd line >= 18 03-05-2018 n/a n/a
HOVON 47 NHL Closed n/a 1st line > 65 03-05-2018 13 39
HOVON 46 NHL Closed n/a 1st line >= 65 03-05-2018 265 73
HOVON 45 MCL Closed n/a 1st line 18 - 65 19-10-2018 87 17
HOVON 44 NHL Closed n/a 2nd line 18 - 65 03-05-2018 232 24
HOVON 43 AML Closed n/a 1st line > 60 19-10-2018 n/a n/a
HOVON 42 AML / SAKK Closed n/a 1st line 18 - 60 03-05-2018 1002 4
HOVON 42 A AML / SAKK Closed n/a 1st line 18 - 60 03-05-2018 514 24
HOVON 41 AL Amyloidosis Closed n/a 1st line < 66 03-05-2018 70 13
HOVON 40 NHL Closed n/a 1st line 18 - 65 03-05-2018 93 21
HOVON 39 NHL / EORTC 20981 Closed n/a 2nd line > 18 03-05-2018 77 32
HOVON 38 CML Closed n/a 1st line 16 - 65 03-05-2018 102 22
HOVON 37 ALL Closed n/a 1st line 16 - 59 03-05-2018 243 12
HOVON 36 MM Closed n/a 1st line > 64 03-05-2018 69 49
HOVON 35 NHL / EORTC 20963 Closed n/a 1st line 18 - 66 03-05-2018 n/a n/a
HOVON 34 MDS / EORTC 06961 Closed n/a 1st line 10 - 60 19-08-2018 n/a n/a
HOVON 32 MDS / ELDERLY AML Closed n/a 1st line 15 - 75 19-08-2018 n/a n/a
HOVON 30 AML Closed n/a 1st line > 18 03-05-2018 80 19
HOVON 29 AML / SAKK 30/95 Closed n/a 1st line 15 - 60 03-05-2018 n/a n/a
HOVON 27 NHL 94 Closed n/a 1st line 15 - 65 03-05-2018 n/a n/a
HOVON 26 NHL Closed n/a 1st line 15 - 65 03-05-2018 486 71
HOVON 25 NHL / OG 95-004 Closed n/a 1st line > 65 03-05-2018 n/a n/a
HOVON 24 MM / OG 96-020 Closed n/a 1st line < 66 03-05-2018 n/a n/a
HOVON 20 CML Closed n/a 1st line > 18 03-05-2018 n/a n/a
HOVON 18 ALL Closed n/a 1st line 16 - 60 03-05-2018 193 19
HOVON-associated HD21 Open Limited site selection - 18-60 20-03-2019 n/a n/a
HOVON-associated DCOne-002 Open Limited site selection 2nd line >= 18 28-01-2019 n/a n/a
HOVON-associated MEDI4736-NHL-001 Closed n/a 2nd line >= 18 18-01-2018 n/a n/a
HOVON-associated MK-3475-087 Closed n/a 2nd line >=18 02-05-2016 n/a n/a
HOVON-associated GO29365 Closed Limited site selection 1st line >=18 14-10-2016 n/a n/a